Insights from daratumumab use in highly sensitized pediatric heart transplant candidates and recipients: A single-center institutional experience and outcomes

By afschroeder • August 19, 2025

Husain M, Butler C, Fan AM, Halnon NJ, Reardon LC, Alejos JC. Insights from daratumumab use in highly sensitized pediatric heart transplant candidates and recipients: A single-center institutional experience and outcomes. JHLT Open. 2025 Jul 17;10:100346. doi: 10.1016/j.jhlto.2025.100346. PMID: 40822087; PMCID: PMC12354783.

Tags: allosensitization, Cardiology/Epi, complex congenital heart disease, daratumumab, desensitization, Pediatric heart transplant, Publications

P2Y12 Inhibitors and Mortality in Patients Hospitalized With Intracerebral Hemorrhage

Jin C, Song Y, Mac Grory B, Sun JL, Alhanti B, Fonarow GC, Schwamm LH, Sheth KN, Smith EE, Messé SR, Saver JL, Bhatt DL,[...]

Clinical Triage of Individuals With Warning Symptoms of Imminent Cardiac Arrest

Reinier K, Chugh H, Kadiyala V, Sargsyan A, Uy-Evanado A, Nakamura K, Heckard E, Mathias M, Grogan T, Elashoff D, Salvucci A, Jui J, Chugh[...]

Nuclear mechanotransduction: tools for mechanical perturbation and chromatin characterization

Soto J, Origer N, Wu Y, Cardenas Benitez B, Massad R, Rahgoshay D, Lee A, Downing T, Li S. Nuclear mechanotransduction: tools for mechanical perturbation[...]